Skip to content

Study · Measured the body's own peptide · 2013

1 result

Dynamic localization of G-actin during membrane protrusion in neuronal motility.

Lee CW, Vitriol EA, Shim S, Wise AL, Velayutham RP, Zheng JQ

Current biology : CB6 Jun 2013Cited by 98 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01LabEndogenous levelIn vitro (cells)Mechanism

    In growth cones and neuroblastoma cells, endogenous thymosin β4 and profilin were identified as key molecules that localize actin monomers to the leading edge of lamellipodia.

    In plain wordsIn cells, the body's own thymosin β4 helps move actin building blocks to the front edge of moving cells.

    Outcome
    Not applicableLocalization of actin monomers to the leading edge by thymosin β4
    Study

    n: not reported in source

    Growth cones and neuroblastoma cells
    Outcome group
    Receptor activity and mechanism · Nervous system and cognition

    Source sentences

    Summary
    Finally, we identify the actin monomer-binding proteins profilin and thymosin β4 as key molecules that localize actin monomers to the leading edge of lamellipodia for their motility.
    1 context sentence
    Summary · context
    Here we report that a pool of G-actin dynamically localizes to the leading edge of growth cones and neuroblastoma cells to spatially elevate the G-/F-actin ratio that drives membrane protrusion and cell movement.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.